HomeFEATURED

FEATURED

EMMA International Consulting Group, Inc. and Thema srl Announce Strategic Partnership

Together, EMMA International and THEMA bring a wealth of knowledge in regulatory affairs, quality management and product development to the medical device industry,” stated Kira Jabri, COO.

DM Clinical Research Opens New Research Site in Boston Area

DM Clinical Research Founder & CEO Mohammad Millwala. “DM Clinical Research is committed to making participation in clinical trials accessible to a broader, more diverse population base. In 2022, minority enrollment for all of our studies was more than 49%. The Boston site enhances our ability to offer research sponsors access to a diverse patient footprint that already includes underserved communities in Chicago, Detroit, Houston and Philadelphia.”

New Hope in Combatting MRSA Superbug in Hospital Infections

Healthcare-Onset MRSA (HO-MRSA) bacteremia infections had a statistically significant 100% decrease (and in fact were eliminated during the trial period) when compared to the same time frame a year prior and the immediate six months prior.

Ginkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza Variants

Ginkgo Bioworks notes the program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airports

Deciphex Rolls Out Automated Image Quality Control for Digital Research Pathology

By building Automated Image QC into Patholytix 3.0, Deciphex delivers dramatically faster turnarounds of studies.

Ordr and GE HealthCare Collaborate to Help Enhance Clinical Network Performance, Efficiency, and Security for Healthcare Providers

GE HealthCare’s service offering for CARESCAPE patient monitoring networks harnesses the power of the Ordr platform to help healthcare systems address top challenges in self-managing and securing clinical assets.

Thirona Spins out the Retina Business to Pursue Long-term Growth Plans

Thirona specializes in artificial intelligence for lung and retinal image analysis allowing for precise quantification of abnormalities related to pulmonary and eye diseases.

Dozee Partners with British International Investment to Transform Public Healthcare in India

Backed by BII’s capital, Dozee will upgrade regular beds to step-down ICUs through the MillionICU initiative – established by Dozee in 2021 to install one million step-down ICU beds across India - and bring about a rapid, long-term transformation in India’s public healthcare infrastructure.

NEUMA, The Design And Testing Arm Of Kymanox, Moves To New Headquarters

The new NEUMA headquarters provides a significant upgrade in meeting space for customer engagement as well as expanded lab space for prototyping and testing.
Exit mobile version